ArticleFrontiers in endocrinology2026
Association between the triglyceride-glucose index and risk of type 2 diabetes mellitus and the mediating effect of BMI: a comparative analysis in Chinese and Japanese populations.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The triglyceride-glucose (TyG) index is a surrogate marker of insulin resistance and metabolic dysregulation. We aimed to examine its association with incident type 2 diabetes mellitus (T2DM) in Chinese and Japanese adults and to quantify the mediating role of body mass index (BMI). However, ethnic differences in the TyG-diabetes association, population-specific thresholds, and potential mediating mechanisms-remain unclear. This study aimed to evaluate the association between the TyG and incident T2DM in Chinese and Japanese adults and to quantify the mediating role of BMI in these associations. Methods: We conducted a retrospective cohort study using data from the China Rich Healthcare Group (n=199,050) and the Japanese NAGALA database (n=15,464). TyG was calculated as ln[fasting triglycerides (mg/dL) ×fasting plasma glucose(mg/dL)/2]. Incident T2DM was defined according to American Diabetes Association criteria. Multivariable Cox models, restricted cubic splines, and two-piecewise regression were used to characterize linear and nonlinear associations between TyG and diabetes risk. Predictive performance was assessed using receiver operating characteristic (ROC) curves. Mediation analysis with 5,000 bootstrap replications quantified the proportion of the TyG-diabetes association mediated by BMI. Results: During a median follow-up of 5.0 years, 2,563 participants developed T2DM. Recent reviews and experimental studies indicate that Japanese adults often develop type 2 diabetes at relatively modest levels of adiposity, frequently with insufficient insulin secretion and a disproportionately high burden of visceral and ectopic fat (fully adjusted HR per 1-unit increase, 2.32; 95% CI, 2.16-2.47), with clear gradients across TyG quartiles in both cohorts. BMI partially mediated the TyG-diabetes association (19.06% in Chinese vs 14.22% in Japanese adults), supporting adiposity-related pathways and population differences in metabolic mediation. Nonlinear analyses suggested cohort-specific inflection points, with risk rising more steeply above TyG ≈8.98 in Chinese and ≈7.88 in Japanese adults. TyG showed moderate discrimination for 5-year diabetes risk (AUC ≈0.74), outperforming triglycerides alone; fasting plasma glucose (FPG) remained more discriminative, and ROC results are reported descriptively. Conclusions: Higher baseline TyG was associated with incident T2DM in both Chinese and Japanese adults, with BMI partially mediating the TyG-diabetes association. These findings suggest that TyG captures triglyceride-glucose dysregulation beyond overall adiposity, with population-specific differences in metabolic pathways. The identification of nonlinear patterns underscores the need for population-tailored risk stratification based on TyG.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.